Back
Business
-
Briefly
NEW DELHI: Strides Arcolab has signed a non-exclusive licence and technical transfer agreement with the U.S.-based bio-pharmaceutical company, Gilead Sciences. The agreement will enable the company to manufacture and distribute generic versions of Truvada and Vlread drugs. It also provides for the manufacture and distribution of a new generation first line therapy in over 90 countries under the Gilead Access Programme.
© Copyright 2000 - 2009 The Hindu |